Catalent Completes Acquisition Of MaSTherCell

Catalent, Inc., the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it had completed its acquisition of MaSTherCell Global Inc., positioning Catalent as a premier technology, development and manufacturing partner for innovators of advanced biotherapeutics.

With the addition of MaSTherCell’s unique portfolio of capabilities, technologies, and related analytical services spanning both autologous and allogeneic cell therapies, Catalent is well positioned to lead the industry with its cell & gene therapy platforms.

The acquisition adds to Catalent’s network MaSTherCell’s 25,000 square-foot clinical services facility in Gosselies, Belgium, and its 32,000 square-foot facility in Houston, Texas, which is focused on development-scale projects and is scheduled to open later this quarter. Catalent will leverage its resources and expertise in build-outs, scale-ups and commercial manufacturing to support the expansion already underway of a 60,000 square-foot commercial-scale cell therapy production and fill-finish facility adjacent to the existing building in Gosselies, which is scheduled to open in the fall of 2021.

Catalent financed the acquisition with the proceeds of an underwritten public offering of its common stock completed last week.

About Catalent
Catalent, Inc. is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,000 people, including over 2,400 scientists and technicians, at more than 35 facilities, and in fiscal year 2019 generated over $2.5B in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com.